Unknown

Dataset Information

0

Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth.


ABSTRACT: Vitamin D insufficiency is widespread in HIV-infected patients. HIV and/or antiretroviral therapy (ART), particularly efavirenz (EFV), may interfere with vitamin D metabolism. However, few data from randomized, controlled trials exist. Here, we investigate changes in vitamin D metabolites and binding protein (VDBP) after 6 months of supplementation in a randomized, active-control, double-blind trial investigating 2 different monthly cholecalciferol (vitamin D3) doses [60,000 (medium) or 120,000 (high) IU/month] vs. a control arm of 18,000 IU/month in 8-25year old HIV-infected youth on ART with HIV-1 RNA <1000 copies/mL and baseline 25-hydroxycholecalciferol (25(OH)D3) ?30ng/mL. A matched healthy uninfected group was enrolled in a similar parallel study for comparison. Changes after 6 months were analyzed as intent-to-treat within/between groups [control group (low dose) vs. combined supplementation doses (medium+high)]. At 6 months, 55% vs. 82% of subjects in control and supplementation groups, respectively, reached 25(OH)D3 ?30ng/mL (P=0.01) with no difference between medium and high doses (both 82% ?30ng/mL). There were few differences for those on EFV vs. no-EFV, except serum VDBP decreased in EFV-treated subjects (both within- and between-groups P?0.01). There were no significant differences between the HIV-infected vs. healthy uninfected groups. The major finding of the present study is that cholecalciferol supplementation (60,000 or 120,000 IU/month) effectively raises serum 25(OH)D3 in the majority of HIV-infected subjects, regardless of EFV use. Notably, response to supplementation was similar to that of uninfected subjects.

PROVIDER: S-EPMC5385603 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC5301352 | BioStudies
| S-EPMC4769970 | BioStudies
| S-EPMC4135028 | BioStudies
| S-EPMC5634602 | BioStudies
| S-EPMC7071343 | BioStudies
| S-EPMC5659607 | BioStudies
| S-EPMC5726464 | BioStudies
| S-EPMC4182952 | BioStudies
| S-EPMC3641012 | BioStudies
| S-EPMC4854371 | BioStudies